In the US, the increasing age of the population is a major risk factor for morbidity and most common diseases such as atherosclerosis, cancers, Parkinson's disease, dementia, and metabolic syndrome. Treatments that increase that portion of the lifespan free of disabling morbidity, i.e., healthspan, in mice, will suggest research directions leading to clinical treatments designed to prevent or retard deleterious changes with age.
Showing the most recent 10 out of 231 publications